Feedback / Questions
BETR-001 - BetterLife Pharma
https://www.globenewswire.com/news-release/2024/04/03/2856884/0/en/BetterLife-Announces-Closing-of-1-168-Million-Convertible-Debentures-to-Further-Advance-IND-enabling-Studies-of-its-Non-hallucinogenic-LSD-based-Drug-Candidate-BETR-001.html
Apr 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next